TET2 and myelodysplastic syndrome: [28] found that the co‐occurrence of SF3B1 with TET2 had a similar prognosis compared to the single SF3B1 mutation, suggesting the effect of the TET2 mutation on the prognosis of SF3B1mut MDS was minimal.